Skip to main content
OpenTrials
Completed

NCT Number: NCT02974036

Patient Enablement in Osteoarthritis - a Longitudinal Study on Patient Education Programs in Primary Health Care

The overall purpose is to study quality in patient education by means of the patients' self-rated enablement. Specific aims are:

To assess the validity of the patient enablement instrument in relation to self-efficacy and empowerment; To investigate if patient enablement can be effective in identifying which patients would benefit the most from patient education; To study if patient enablement has any relation to self-efficacy, function or self-rated health; To analyze if patient enablement has a causal effect on health care consumption; To evaluate whether patient education is a cost-effective intervention. The project is a longitudinal study, including patients from a patient education programme for osteoarthritis in primary health care. Data consist of patient reported outcome measures and health care consumption. Cost-effectiveness and cost-utility analysis will be used. Inclusion of patients will start August 2016. Analyses of data and manuscript writing will be performed in 2018-2019. Researchers included are from primary health care settings and researchers in the field of OA, patient education and health economy. Our increasingly older and more inactive population will raise huge demands on the health care. The importance of optimizing treatments that are available in primary health care cannot be underestimated. The project will contribute with important knowledge about the patient's own process of getting well.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

Primary Health Care

Malmö, SE20502, Sweden

About this study

The project is a longitudinal study, including patients who are referred to patient education for osteoarthritis in primary health care and is planned to follow the patients one year before baseline measures as well as one year after baseline measures.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients who are referred to patient education for OA in primary health care
  • Speaks and write Swedish

Exclusion criteria

  • Not having OA
  • Not able to speak or write Swedish

Treatment and study plan

Patient education for osteoarthritis

Other

Group sessions and optional supervised exercise.

Primary outcomes

  1. Patient enablement

    Time frame: directly after intervention

    Questionnaire

Secondary outcomes

  1. Arthritis Self Efficacy Scale

    Time frame: before intervention, directly after intervention and at 3 and 9 month follow up

    Questionnaire

Other outcomes

  1. Swedish Rheumatic Empowerment Scale

    Time frame: Before intervention, directly after intervention and at 3 and 9 month follow up

    Questionnaire

  2. EQ5D index

    Time frame: Before intervention, directly after intervention and at 3 and 9 month follow up

    Questionnaire

  3. Health care consumption

    Time frame: 12 months before baseline and 12 months after baseline

    Linked register data from the Skåne Health Care Register

  4. Sick leave

    Time frame: 12 months before baseline and 12 months after baseline

    Linked register data from the Swedish Social Insurance Agency

  5. EQ5D Health barometer

    Time frame: Before intervention, directly after intervention and at 3 and 9 month follow up

    visual analogue scale

Sponsors and collaborators

Lead sponsor

Lund University

Other

Registry information

Important dates

Study start
2016
Primary completion
2019
Study completion
2019
First posted
Nov 28, 2016
Registry last updated
Mar 14, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.